The plan to pay for the popular anti-obesity medications for 7.5 million Medicare and Medicaid beneficiaries would cost the federal government tens of billions of dollars. But the incoming Trump administration could block the plan, and Robert F. Kennedy Jr., the president-elect's choice for secretary of Health and Human Services, is an avowed enemy of the drugs. |
No comments:
Post a Comment